COMPANY OVERVIEW

Indalo Therapeutics is a biopharmaceutical company discovering and developing novel integrin antagonists for patients suffering from serious fibrotic diseases.

---

LOCATION

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Fibrotic DIsease

---

WEBSITE

https://www.indalotherapeutics.com

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Dec 17, 2019

Indalo Therapeutics Appoints Healthcare Industry Veteran and Serial Entrepreneur Michael Heffernan as Board Chair

Nov 11, 2019

Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965

Oct 21, 2019

Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965

Apr 18, 2019

Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965

Jan 28, 2019

Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President and CEO

For More Press Releases

---